Scientific research in circadian rhythm has determined that our genes can quite accurately predict the time of our death due to natural causes….Read More
We all know bacon and other fatty foods can lead to obesity, diabetes, and cardiovascular diseases but the four-legged creature from where these foods come has become an international sensation with regards to its use in scientific research. Pigs are used in efficacy and toxicity models to study cardiovascular disease, diabetes and obesity, and even has applications in dermatology and inflammation.
The pig has become a superstar in scientific research, primarily in its use as a valid animal model to study human diseases. The Swine Genome Sequencing Consortium, in their efforts to better understand pig evolution/domestication, production and health monitoring, and applications for biomedical research, has identified 112 genes in pigs that are also responsible for human metabolic disorders . With such similarities, pigs can be used for drug testing in applications of various therapeutic areas.Read More
We have seen a recent interest for Caenorhabditis elegans (C. elegans) research services and wanted to share with our users exactly how useful this little worm in pharmaceutical research is turning out to be the study of Parkinson’s Disease (PD) has led to the development of many pharmacological models from transgenic rodents to non-human primates, and now worms (the aforementioned C. elegans, to be exact).
Many researchers have taken advantage of this tiny, transparent worm to study PD as well as Alzheimer’s disease, cystic fibrosis, ALS, epilepsy, and dystonia. The worm possesses a nervous system, digestive tract, musculature and reproductive system, which are all clearly visible with the use of fluorescent proteins inserted through genetic engineering.Read More
Shortly after coming across a story about a mother and father who are forced to relocate to another country in order to obtain treatment for their baby son’s rare disease, we took notice of another American family with a child who shares a disease with less than thirty people in the United States take matters into their own hands and pursue the development of a possible treatment. Their story is documented in an upcoming film, “RARE”.Read More